Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Armkel update

Executive Summary

Nair depilatory and Arrid antiperspirant manufacturing move to Church & Dwight's Lakewood, N.J. facility from Carter-Wallace's Cranbury, N.J. location will be completed by second quarter, C&D Chief Financial Officer and Director of Armkel Integration Zvi Eiref says. C&D acquired Nair from Carter-Wallace in a 50/50 joint venture with Kelso in May and purchased C-W antiperspirant business in a second transaction (1"The Rose Sheet" May 14, 2001, p. 9). Move will result in 600 job cuts and severance costs of $15 mil., firm adds during April 4 analyst call. Financials for the JV from Sept. 28, when the acquisition was completed, through Dec. 31 were in line with preliminary reports issued in February, with revenues of $95.4 mil., and a net loss of $15.6 mil. (2"The Rose Sheet" Feb. 18, 2002, p. 9)...
Advertisement

Related Content

Nair Spa Kit, Wax Strip Extensions Aimed To Counter Share Declines
Church & Dwight U.S. Personal Care Sales Near $500 Mil. With C-W Brands
Church & Dwight U.S. Personal Care Sales Near $500 Mil. With C-W Brands
Advertisement
UsernamePublicRestriction

Register

RS010172

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel